/Abbott%20Laboratories%20vials%20and%20Logo-by%20Melniov%20Dmitriy%20via%20Shutterstock.jpg)
Headquartered in North Chicago, Illinois, Abbott Laboratories (ABT) is a global leader in healthcare, specializing in discovering, developing, manufacturing, and distributing innovative medical solutions. Valued at $175.23 billion by market cap, Abbott is renowned for its pioneering diagnostic tools, transformative medical devices, and advanced nutritional offerings. ABT’s groundbreaking contributions include the FreeStyle Libre, a revolutionary continuous glucose monitoring system that has redefined diabetes management worldwide.
Abbott shares significantly underperformed the broader market over the past year. The stock has declined 2.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 25.2%. In 2024 alone, the stock has lost 8.5%, compared to SPX's 10.4% gains on a YTD basis.